The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-02
DOI
10.3389/fphar.2021.701390
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetes, obesity, metabolism and SARS-CoV-2 infection: The end of the beginning
- (2021) Daniel J. Drucker Cell Metabolism
- Insulin signaling in health and disease
- (2021) Alan R. Saltiel JOURNAL OF CLINICAL INVESTIGATION
- Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease
- (2021) Lili Sheng et al. Frontiers in Pharmacology
- Silencing Epidermal Growth Factor Receptor in HypothalamicParaventricular Nucleus Reduces Extracellular Signal-regulated Kinase 1 and 2 ERK1/2Signaling and Sympathetic Excitation in Heart Failure Rats
- (2021) Yang Yu et al. NEUROSCIENCE
- Epidermal growth factor receptor-dependent maintenance of cardiac contractility
- (2021) Shuchi Guo et al. CARDIOVASCULAR RESEARCH
- Endothelial epidermal growth factor receptor is of minor importance for vascular and renal function and obesity-induced dysfunction in mice
- (2021) Barbara Schreier et al. Scientific Reports
- Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk
- (2021) Cristina Colom et al. Journal of Clinical Medicine
- Diabetic Complications and Oxidative Stress: A 20-Year Voyage Back in Time and Back to the Future
- (2021) Carla Iacobini et al. Antioxidants
- Understanding Metabolic Memory: A Tale of Two Studies
- (2020) Rachel G. Miller et al. DIABETES
- Amphiregulin promotes cardiac fibrosis post myocardial infarction by inducing the endothelial-mesenchymal transition via the EGFR pathway in endothelial cells
- (2020) Liang Liu et al. EXPERIMENTAL CELL RESEARCH
- The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor
- (2020) Hai-Lian Bi et al. Science Advances
- 455-P: Pan-ErbB Inhibition Attenuates Diabetes-Induced Vascular Dysfunction in an Experimental Model of Diabetes
- (2020) SAGHIR AKHTAR et al. DIABETES
- Knockout of vascular smooth muscle EGF receptor in a mouse model prevents obesity-induced vascular dysfunction and renal damage in vivo
- (2020) Christian Stern et al. DIABETOLOGIA
- Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety
- (2020) Saghir Akhtar et al. JOURNAL OF DRUG TARGETING
- (-)-Epigallocatechin-3-Gallate Inhibits eNOS Uncoupling and Alleviates High Glucose-Induced Dysfunction and Apoptosis of Human Umbilical Vein Endothelial Cells by PI3K/AKT/eNOS Pathway
- (2020) Zhiyong Zhang et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
- (2020) Matthias P. Nägele et al. ATHEROSCLEROSIS
- Preventive Role of Diet Interventions and Dietary Factors in Type 2 Diabetes Mellitus: An Umbrella Review
- (2020) Phung Lam Toi et al. Nutrients
- EGFR and anti-EGFR nanobodies: review and update
- (2020) Jafar Sharifi et al. JOURNAL OF DRUG TARGETING
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Heart Failure in Type 2 Diabetes Mellitus
- (2019) Helena C. Kenny et al. CIRCULATION RESEARCH
- Epidermal growth factor protects against myocardial ischaemia reperfusion injury through activating Nrf2 signalling pathway
- (2019) Jun Ma et al. FREE RADICAL RESEARCH
- Chronic administration of nano-sized PAMAM dendrimers in vivo inhibits EGFR-ERK1/2-ROCK signaling pathway and attenuates diabetes-induced vascular remodeling and dysfunction
- (2019) Saghir Akhtar et al. Nanomedicine-Nanotechnology Biology and Medicine
- Topical Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Clinical Trials
- (2019) Qi Yang et al. ANNALS OF VASCULAR SURGERY
- ER stress response mediates diabetic microvascular complications
- (2019) Himanshu Sankrityayan et al. DRUG DISCOVERY TODAY
- Counter-regulatory renin–angiotensin system in cardiovascular disease
- (2019) Maria Paz Ocaranza et al. Nature Reviews Cardiology
- The heart of a hibernator: EGFR and MAPK signaling in cardiac muscle during the hibernation of thirteen-lined ground squirrels, Ictidomys tridecemlineatus
- (2019) Christine L. Childers et al. PeerJ
- Transcription-independent Induction of ERBB1 through Hypoxia-inducible Factor 2A Provides Cardioprotection during Ischemia and Reperfusion
- (2019) Jae W. Lee et al. ANESTHESIOLOGY
- Mechanisms of the Multitasking Endothelial Protein NRG-1 as a Compensatory Factor During Chronic Heart Failure
- (2019) Gilles W. De Keulenaer et al. Circulation-Heart Failure
- Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation
- (2019) Miles A. Tanner et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
- (2019) Yixuan Zhang et al. Nature Reviews Cardiology
- Ang-(1-7)/ MAS1 receptor axis inhibits allergic airway inflammation via blockade of Src-mediated EGFR transactivation in a murine model of asthma
- (2019) Ahmed Z. El-Hashim et al. PLoS One
- Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR-dependent pathway
- (2018) Liang Liu et al. BASIC RESEARCH IN CARDIOLOGY
- Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3/matrix metalloproteinase 2/epidermal growth factor receptor signalling
- (2018) Caojian Zuo et al. CARDIOVASCULAR RESEARCH
- Vascular smooth muscle contraction in hypertension
- (2018) Rhian M Touyz et al. CARDIOVASCULAR RESEARCH
- Conflicting roles of 20-HETE in hypertension and renal end organ damage
- (2018) Chao Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Growth factors in the pathogenesis of diabetic foot ulcers
- (2018) Jianglin Zhang Frontiers in Bioscience-Landmark
- SHBG expression is correlated with PI3K/AKT pathway activity in a cellular model of human insulin resistance
- (2018) Chong Feng et al. GYNECOLOGICAL ENDOCRINOLOGY
- Cellular death, reactive oxygen species (ROS) and diabetic complications
- (2018) Caroline Maria Oliveira Volpe et al. Cell Death & Disease
- Osteoglycin, a novel coordinator of bone and glucose homeostasis
- (2018) N.J. Lee et al. Molecular Metabolism
- Matrix metalloproteinase-2-induced epidermal growth factor receptor transactivation impairs redox balance in vascular smooth muscle cells and facilitates vascular contraction
- (2018) Alejandro F. Prado et al. Redox Biology
- Epstein–Barr Virus in Gliomas: Cause, Association, or Artifact?
- (2018) Saghir Akhtar et al. Frontiers in Oncology
- EGFR inhibitor, AG1478, inhibits inflammatory infiltration and angiogenesis in mice with diabetic retinopathy
- (2018) Xin Ju et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- EGFR tyrosine kinase inhibition decreases cardiac remodeling and SERCA2a/NCX1 depletion in streptozotocin induced cardiomyopathy in C57/BL6 mice
- (2018) Sadia Shah et al. LIFE SCIENCES
- 20-HETE in the regulation of vascular and cardiac function
- (2018) Petra Rocic et al. PHARMACOLOGY & THERAPEUTICS
- Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)
- (2018) Mikhail Kosiborod et al. Cardiovascular Diabetology
- Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage
- (2018) Sandra Rayego-Mateos et al. MEDIATORS OF INFLAMMATION
- Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers
- (2018) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Favorable Vascular Actions of Angiotensin-(1–7) in Human ObesityNovelty and Significance
- (2017) Francesca Schinzari et al. HYPERTENSION
- Transactivation of the epidermal growth factor receptor in responses to myocardial stress and cardioprotection
- (2017) Melissa E. Reichelt et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Myocardial ischemia/reperfusion upregulates the transcription of the Neuregulin1 receptor ErbB3, but only postconditioning preserves protein translation: Role in oxidative stress
- (2017) Michela Morano et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Nexus Implicated in Bowel Disease Pathophysiology
- (2017) Wai Chong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neuregulin-1β induces proliferation, survival and paracrine signaling in normal human cardiac ventricular fibroblasts
- (2017) Annet Kirabo et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way
- (2017) Deborah R. Leitner et al. Obesity Facts
- Inhibition of endoplasmic reticulum stress by neuregulin-1 protects against myocardial ischemia/reperfusion injury
- (2017) Shan-Juan Fang et al. PEPTIDES
- Essential role for EGFR tyrosine kinase and ER stress in myocardial infarction in type 2 diabetes
- (2017) Vishal Mali et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress
- (2017) Zheng Xu et al. Oncotarget
- Macro- and microvascular endothelial dysfunction in diabetes
- (2017) Yi Shi et al. Journal of Diabetes
- Cardio-oncology Related to Heart Failure
- (2017) Benjamin Kenigsberg et al. Heart Failure Clinics
- NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes
- (2017) Sachin V. Suryavanshi et al. Frontiers in Pharmacology
- Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study
- (2017) Rients P. T. van Wijngaarden et al. Diabetes Therapy
- Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study
- (2017) Rients P. T. van Wijngaarden et al. Diabetes Therapy
- Endothelial CaMKII as a regulator of eNOS activity and NO-mediated vasoreactivity
- (2017) Shubha Murthy et al. PLoS One
- Endogenous angiotensin-(1-7)/Mas receptor/NO pathway mediates the cardioprotective effects of pacing postconditioning
- (2016) Ala'a Abwainy et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System
- (2016) Steven J. Forrester et al. Annual Review of Pharmacology and Toxicology
- Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid
- (2016) Victor Garcia et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Neuregulin 1 improves glucose tolerance in adult and old rats
- (2016) K. Caillaud et al. DIABETES & METABOLISM
- Molecular mechanisms in differentiated thyroid cancer
- (2016) Youben Fan Frontiers in Bioscience-Landmark
- Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
- (2016) Kesong Peng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Naked Polyamidoamine Polymers Intrinsically Inhibit Angiotensin II-Mediated EGFR and ErbB2 Transactivation in a Dendrimer Generation- and Surface Chemistry-Dependent Manner
- (2016) Saghir Akhtar et al. MOLECULAR PHARMACEUTICS
- The epidermal growth factor receptor pathway in chronic kidney diseases
- (2016) Laura R. Harskamp et al. Nature Reviews Nephrology
- Causes and consequences of endoplasmic reticulum stress in rheumatic disease
- (2016) Fatemeh Navid et al. Nature Reviews Rheumatology
- Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease
- (2016) Jianchun Chen et al. PHYSIOLOGICAL REVIEWS
- Diabetic retinopathy
- (2016) Tien Y. Wong et al. Nature Reviews Disease Primers
- EGFR Inhibition Blocks Palmitic Acid-induced inflammation in cardiomyocytes and Prevents Hyperlipidemia-induced Cardiac Injury in Mice
- (2016) Weixin Li et al. Scientific Reports
- Diabetes and hyperlipidemia induce dysfunction of VSMCs: contribution of the metabolic inflammation/miRNA pathway
- (2015) Tao Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension
- (2015) Victor Garcia et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat
- (2015) Fan Fan et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Crosstalk Between MAPK/ERK and PI3K/AKT Signal Pathways During Brain Ischemia/Reperfusion
- (2015) Jing Zhou et al. ASN Neuro
- Augmented EGF receptor tyrosine kinase activity impairs vascular function by NADPH oxidase-dependent mechanism in type 2 diabetic mouse
- (2015) Modar Kassan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic mice
- (2015) Modar Kassan et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Epidermal growth factor induces Ca2+ sensitization through Rho-kinase-dependent phosphorylation of myosin phosphatase target subunit 1 in vascular smooth muscle
- (2015) Tomoya Sasahara et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes
- (2015) Ibrahim F. Benter et al. JOURNAL OF DRUG TARGETING
- Zinc pyrithione inhibits caspase-3 activity, promotes ErbB1-ErbB2 heterodimerization and suppresses ErbB2 downregulation in cardiomyocytes subjected to ischemia/reperfusion
- (2015) Vijaya Lakshmi Bodiga et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Diabetic cardiomyopathy: Role of epidermal growth factor receptor tyrosine kinase
- (2015) Zheng Xu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model
- (2015) Dandan Liang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Vascular nitric oxide: Beyond eNOS
- (2015) Yingzi Zhao et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- The beta-cell in type 1 diabetes: What have we learned from proteomic studies?
- (2015) Inne Crèvecoeur et al. Proteomics Clinical Applications
- Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?
- (2015) Athanasios Fountas et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor
- (2015) Saghir Akhtar et al. PLoS One
- Angiotensin-(1-7) attenuates angiotensin II-induced signalling associated with activation of a tyrosine phosphatase in Sprague-Dawley rats cardiac fibroblasts
- (2014) Xiaoling Tao et al. BIOLOGY OF THE CELL
- Angiotensin II and Vascular Injury
- (2014) Augusto C. Montezano et al. CURRENT HYPERTENSION REPORTS
- Role of epidermal growth factor receptor in vascular structure and function
- (2014) Barbara Schreier et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Transactivation of ErbB Receptors by Leptin in the Cardiovascular System: Mechanisms, Consequences and Target for Therapy
- (2014) Jerzy Beltowski et al. CURRENT PHARMACEUTICAL DESIGN
- Transactivation of EGFR by G Protein-Coupled Receptor in the Pathophysiology of Intimal Hyperplasia
- (2014) Swastika Sur et al. Current Vascular Pharmacology
- Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity
- (2014) Lucas Liaudet et al. HEART FAILURE REVIEWS
- Islet inflammation in human type 1 diabetes mellitus
- (2014) Noel G. Morgan et al. IUBMB LIFE
- The pathobiology of diabetic vascular complications—cardiovascular and kidney disease
- (2014) Stephen P. Gray et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- EGF Receptor Deletion in Podocytes Attenuates Diabetic Nephropathy
- (2014) J. Chen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Erbb2 Is Required for Cardiac Atrial Electrical Activity during Development
- (2014) Gennadiy Tenin et al. PLoS One
- Viruses exploit the function of epidermal growth factor receptor
- (2014) Kai Zheng et al. REVIEWS IN MEDICAL VIROLOGY
- Examining the Protective Role of ErbB2 Modulation in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
- (2014) Sandy Eldridge et al. TOXICOLOGICAL SCIENCES
- Chronic Treatment with Ang-(1-7) Reverses Abnormal Reactivity in the Corpus Cavernosum and Normalizes Diabetes-Induced Changes in the Protein Levels of ACE, ACE2, ROCK1, ROCK2 and Omega-Hydroxylase in a Rat Model of Type 1 Diabetes
- (2014) Mariam H. M. Yousif et al. Journal of Diabetes Research
- Update on the Angiotensin Converting Enzyme 2-Angiotensin (1–7)-Mas Receptor Axis: Fetal Programing, Sex Differences, and Intracellular Pathways
- (2014) Mark C. Chappell et al. Frontiers in Endocrinology
- Catechin Averts Experimental Diabetes Mellitus-Induced Vascular Endothelial Structural and Functional Abnormalities
- (2013) Pooja Bhardwaj et al. Cardiovascular Toxicology
- Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications
- (2013) Vaibhav B. Patel et al. CLINICAL SCIENCE
- Vascular smooth muscle function in type 2 diabetes mellitus: a systematic review and meta-analysis
- (2013) David Montero et al. DIABETOLOGIA
- Alterations in cardiac DNA methylation in human dilated cardiomyopathy
- (2013) Jan Haas et al. EMBO Molecular Medicine
- Role of angiotensin II and angiotensin-(1–7) in diabetes-induced oxidative DNA damage in the corpus cavernosum
- (2013) Narayana Kilarkaje et al. FERTILITY AND STERILITY
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Intravenous Glial Growth Factor 2 (GGF2) Isoform of Neuregulin-1β Improves Left Ventricular Function, Gene and Protein Expression in Rats after Myocardial Infarction
- (2013) Michael F. Hill et al. PLoS One
- Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction
- (2013) Saghir Akhtar et al. PLoS One
- Induction of Angiotensin-Converting Enzyme and Activation of the Renin–Angiotensin System Contribute to 20-Hydroxyeicosatetraenoic Acid–Mediated Endothelial Dysfunction
- (2012) Jennifer Cheng et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- FOXOs and Sirtuins in Vascular Growth, Maintenance, and Aging
- (2012) Mark F. Oellerich et al. CIRCULATION RESEARCH
- Therapeutic effects of neuregulin-1 gene transduction in rats with myocardial infarction
- (2012) Jian Xiao et al. CORONARY ARTERY DISEASE
- Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta-analysis
- (2012) Sebhat Erqou et al. EUROPEAN JOURNAL OF HEART FAILURE
- Role of Forkhead Transcription Factors in Diabetes-Induced Oxidative Stress
- (2012) Bhaskar Ponugoti et al. Experimental Diabetes Research
- The Epidermal Growth Factor Receptor
- (2012) Tomonori Kobayashi et al. HYPERTENSION
- A Novel Role for Epidermal Growth Factor Receptor Tyrosine Kinase and Its Downstream Endoplasmic Reticulum Stress in Cardiac Damage and Microvascular Dysfunction in Type 1 Diabetes Mellitus
- (2012) Maria Galán et al. HYPERTENSION
- Insulin resistance: An adaptive mechanism becomes maladaptive in the current environment — An evolutionary perspective
- (2012) Agathocles Tsatsoulis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Characterization of Angiotensin-(1–7) effects on the cardiovascular system in an experimental model of Type-1 diabetes
- (2012) Mariam H.M. Yousif et al. PHARMACOLOGICAL RESEARCH
- Activation of EGFR/ERBB2 via Pathways Involving ERK1/2, P38 MAPK, AKT and FOXO Enhances Recovery of Diabetic Hearts from Ischemia-Reperfusion Injury
- (2012) Saghir Akhtar et al. PLoS One
- Krüppel-Like Factor 2 Suppression by High Glucose as a Possible Mechanism of Diabetic Vasculopathy
- (2012) Hae-Young Lee et al. Korean Circulation Journal
- Chronic Inhibition of Epidermal Growth Factor Receptor Tyrosine Kinase and Extracellular Signal-Regulated Kinases 1 and 2 (ERK1/2) Augments Vascular Response to Limb Ischemia in Type 2 Diabetic Mice
- (2011) Soo-Kyoung Choi et al. AMERICAN JOURNAL OF PATHOLOGY
- Essential role of EGFR in cardioprotection and signaling responses to A1 adenosine receptors and ischemic preconditioning
- (2011) Grant Williams-Pritchard et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardiac-specific overexpression of E3 ligase Nrdp1 increases ischemia and reperfusion-induced cardiac injury
- (2011) Yuan Zhang et al. BASIC RESEARCH IN CARDIOLOGY
- Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway
- (2011) Saghir Akhtar et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Role of Nitric Oxide on Endothelial Function
- (2011) Dimitris Tousoulis et al. Current Vascular Pharmacology
- Nitric oxide synthases: regulation and function
- (2011) U. Forstermann et al. EUROPEAN HEART JOURNAL
- Endoplasmic Reticulum Stress and Diabetic Cardiomyopathy
- (2011) Jiancheng Xu et al. Experimental Diabetes Research
- Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment
- (2011) Inês Falcão-Pires et al. HEART FAILURE REVIEWS
- Aldosterone Stimulates the Cardiac Na + /H + Exchanger via Transactivation of the Epidermal Growth Factor Receptor
- (2011) Verónica C. De Giusti et al. HYPERTENSION
- Angiotensin-(1-7) Blockade Attenuates Captopril- or Hydralazine-induced Cardiovascular Protection in Spontaneously Hypertensive Rats Treated With NG-nitro-l-Arginine Methyl Ester
- (2011) Ibrahim F Benter et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages
- (2011) Laura L. Souza et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Endothelial Dysfunction in the Apolipoprotein E-deficient Mouse: insights into the influence of diet, gender and aging
- (2011) Silvana S Meyrelles et al. Lipids in Health and Disease
- Angiotensin II causes endothelial dysfunction via the GRK2/Akt/eNOS pathway in aortas from a murine type 2 diabetic model
- (2011) Kumiko Taguchi et al. PHARMACOLOGICAL RESEARCH
- 20-HETE in neovascularization
- (2011) Li Chen et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Resveratrol Shows Vasoprotective Effect Reducing Oxidative Stress Without Affecting Metabolic Disturbances in Insulin-dependent Diabetes of Rabbits
- (2010) Fatma Akar et al. CARDIOVASCULAR DRUGS AND THERAPY
- GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats
- (2010) Prabhakara Reddy Nagareddy et al. CARDIOVASCULAR RESEARCH
- Oxidative Stress and Diabetic Complications
- (2010) Ferdinando Giacco et al. CIRCULATION RESEARCH
- Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses
- (2010) Andrew Jabbour et al. EUROPEAN JOURNAL OF HEART FAILURE
- Angiotensin-(1–7) prevents diabetes-induced attenuation in PPAR-γ and catalase activities
- (2010) Gursev S. Dhaunsi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- CYP4A2-Induced Hypertension Is 20-Hydroxyeicosatetraenoic Acid– and Angiotensin II–Dependent
- (2010) Komal Sodhi et al. HYPERTENSION
- Expression, localization, and regulation of the neuregulin receptor ErbB3 in mouse heart
- (2010) Genís Campreciós et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure
- (2010) Runlin Gao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mechanisms of myogenic tone of coronary arteriole: Role of down stream signaling of the EGFR tyrosine kinase
- (2010) Ali H. Amin et al. MICROVASCULAR RESEARCH
- ErbB signaling in cardiac development and disease
- (2010) Pablo Sanchez-Soria et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Role of epidermal growth factor receptor (EGFR) in corneal remodelling in diabetes
- (2009) Saeed Akhtar et al. ACTA OPHTHALMOLOGICA
- Cardioprotection of bradykinin at reperfusion involves transactivation of the epidermal growth factor receptor via matrix metalloproteinase-8
- (2009) C. Methner et al. Acta Physiologica
- Epidermal growth factor receptor regulates pancreatic fibrosis
- (2009) Stacy A. Blaine et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- 20-HETE can act as a nonhypoxic regulator of HIF-1α in human microvascular endothelial cells
- (2009) Austin M. Guo et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase
- (2009) Khalid Matrougui DIABETES-METABOLISM RESEARCH AND REVIEWS
- 20-Hydroxy-5,8,11,14-eicosatetraenoic Acid Mediates Endothelial Dysfunction via I B Kinase-Dependent Endothelial Nitric-Oxide Synthase Uncoupling
- (2009) J. Cheng et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy
- (2009) Pedro Geraldes et al. NATURE MEDICINE
- Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats
- (2009) May Al-Maghrebi et al. PHARMACOLOGICAL RESEARCH
- Early inhibition of EGFR signaling prevents diabetes-induced up-regulation of multiple gene pathways in the mesenteric vasculature
- (2009) Ibrahim F. Benter et al. VASCULAR PHARMACOLOGY
- Cardiac ErbB-1/ErbB-2 mutant expression in young adult mice leads to cardiac dysfunction
- (2008) Viswanathan Rajagopalan et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Elevated Epidermal Growth Factor Receptor Phosphorylation Induces Resistance Artery Dysfunction in Diabetic db/db Mice
- (2008) S. Belmadani et al. DIABETES
- Role of elevated EGFR phosphorylation in the induction of structural remodelling and altered mechanical properties of resistance artery from type 2 diabetic mice
- (2008) Desiree I. Palen et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Vascular System: Role of Nitric Oxide in Cardiovascular Diseases
- (2008) Ka Bian et al. Journal of Clinical Hypertension
- ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium
- (2008) Stephen J. Fuller et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- UKPDS and the Legacy Effect
- (2008) John Chalmers et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of α-lipoic acid on endothelial function in aged diabetic and high-fat fed rats
- (2007) C M Sena et al. BRITISH JOURNAL OF PHARMACOLOGY
- Role of Ca2+/calmodulin-dependent protein kinase II in development of vascular dysfunction in diabetic rats with hypertension
- (2007) Mariam H. M. Yousif et al. CELL BIOCHEMISTRY AND FUNCTION
- Chronic pharmacologic inhibition of EGFR leads to cardiac dysfunction in C57BL/6J mice
- (2007) Cordelia J. Barrick et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started